Bionor Pharma is a leading vaccine company, searching for breakthrough treatments for HIV and other deadly viruses.

Modified Peptide based vaccinesen/Vaccines_+_technology/Platform_technology/The key to kill virusen/Vaccines_+_technology/Platform_technology/Vacc-4x kills virus producing cells.en/Vaccines_+_technology/HIV_vaccine_Vacc-4x/

Latest news

Hide mandatory notifications of trade

Mandatory Notification of Trade

Financial .2014

(Oslo, Norway, 14 October 2014) Bionor Pharma ASA Deputy Chairman Øystein Soug’s directly owned company Abakus Invest AS has on 13 October bought 79 545 shares in Bionor Pharma from Øystein Soug at NOK 2,38.Abakus Invest AS holds 107,205 shares after the transaction.

Go to news section

Featured content